Financial Consulate’s Roivant Sciences ROIV Stock Holding History

Financial Consulate’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$695	Buy	+19	New	+$689	﹤0.01%	1380

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Cache Advisors San Francisco, California $1.63B AUM 33.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Financial Consulate's ROIV Position: Q3 2026 in Review

Financial Consulate opened a new position in Roivant Sciences (ROIV) in Q3 2026: 19 shares worth $695. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings.

93 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Financial Consulate held 19 shares of Roivant Sciences worth $695 as of Q3 2026.
Roivant Sciences was a new Financial Consulate position in Q3 2026.
Roivant Sciences made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1380 holding.
93 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.